NCT03291041View on ClinicalTrials.gov

A Proof of Concept Study to Evaluate the Effects of Tasimelteon and Placebo in Travelers With Jet Lag Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

November 30, 2017

Study Completion Date

November 30, 2017

Conditions
Jet Lag Disorder
Interventions
DRUG

Tasimelteon

capsule

DRUG

Placebo

capsule

Trial Locations (3)

20815

Vanda Investigational Site, Chevy Chase

90404

Vanda Investigational Site, Santa Monica

94501

Vanda Investigational Site, Alameda

Sponsors
All Listed Sponsors
lead

Vanda Pharmaceuticals

INDUSTRY